|
|
Volumn 134, Issue 13, 2009, Pages 651-652
|
|
Biological half-life of bisphosphonates;Biologische halbwertszeit von bisphosphonaten
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
COLECALCIFEROL;
IBANDRONIC ACID;
RISEDRONIC ACID;
ZOLEDRONIC ACID;
VITAMIN D;
APOPTOSIS;
CANCER PATIENT;
CARDIOVASCULAR EFFECT;
CYTOKINE PRODUCTION;
DRUG CONTRAINDICATION;
DRUG HALF LIFE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
IMMUNOSUPPRESSIVE TREATMENT;
IN VIVO STUDY;
LETTER;
MACROPHAGE;
MONOCYTE;
OSTEOCLAST;
OSTEOMYELITIS;
OSTEOPOROSIS;
PSORIASIS VULGARIS;
BONE;
BONE TUMOR;
CHEMISTRY;
DRUG EFFECT;
HALF LIFE TIME;
JAW;
METABOLISM;
NECROSIS;
PATHOLOGY;
PH;
BONE AND BONES;
BONE NEOPLASMS;
CALCIUM;
DIPHOSPHONATES;
HALF-LIFE;
HUMANS;
HYDROGEN-ION CONCENTRATION;
JAW;
NECROSIS;
OSTEOCLASTS;
OSTEOPOROSIS;
VITAMIN D;
|
|
EID: 62749102794
PISSN: 00120472
EISSN: 14394413
Source Type: Journal
DOI: 10.1055/s-0029-1208102 Document Type: Letter |
|
Times cited : (3)
|
|
References (1)
|
